Sotera Health Company

Historical 13F Holders

Symbol
SHC
CUSIP
83601L102
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 83601L102 since 12/18/2024, newest first.

Filer % of Class Filed
Sachem Head Capital Management LP 13G/A Amendment 1
0% 10/9/2026
Event 10/9/2026
Sculptor Capital LP 13G/A Amendment 2
8.4% 8/14/2026
Event 6/30/2026
Sessa Capital IM, L.P. 13G/A Amendment 1
9.5% 8/14/2026
Event 6/30/2026
BlackRock, Inc. 13G/A Amendment 2 8.4% 7/30/2026
Event 6/30/2026
Warburg Pincus & Co. 13G/A Amendment 6
0% 5/15/2026
Event 3/6/2026
GTCR Investment XI LLC 13G/A Amendment 7
0% 5/15/2026
Event 5/13/2026
Sachem Head Capital Management LP 13G
5.5% 5/15/2026
Event 5/11/2026
Vanguard Group Inc 13G/A Amendment 3 0% 3/27/2026
Event 3/13/2026
Warburg Pincus & Co. 13G/A Amendment 5
11.2% 3/10/2026
Event 3/6/2026
GTCR Investment XI LLC 13G/A Amendment 6
11.2% 3/10/2026
Event 3/6/2026
Sessa Capital (Master), L.P. 13G
7.2% 2/17/2026
Event 12/31/2025
Sculptor Capital LP 13G/A Amendment 1
7.4% 2/13/2026
Event 12/31/2025
Vanguard Group Inc 13G/A Amendment 2 6.8% 1/30/2026
Event 12/31/2025
BlackRock, Inc. 13G/A Amendment 1 6.2% 1/21/2026
Event 12/31/2025
GTCR Investment XI LLC 13G/A Amendment 5
20.0% 12/19/2025
Event 12/3/2025
Darsana Capital Partners LP 13G/A Amendment 1
8.8% 11/14/2025
Event 9/30/2025
Warburg Pincus & Co. 13G/A Amendment 4
25.7%
Checked 5% or less
11/12/2025
Event 11/10/2025
GTCR Investment XI LLC 13G/A Amendment 4
25.7% 11/12/2025
Event 11/10/2025
BlackRock, Inc. 13G 5.2% 10/17/2025
Event 9/30/2025
Sculptor Capital LP 13G
5.2% 9/11/2025
Event 9/4/2025
Warburg Pincus & Co. 13G/A Amendment 3
36.3%
Checked 5% or less
9/10/2025
Event 9/5/2025
GTCR Investment XI LLC 13G/A Amendment 3
36.3% 9/10/2025
Event 9/5/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 12 7.04 M $130 M
2026 Q2 324 300 M $5.51 B
2026 Q1 304 276 M $3.94 B
2025 Q4 293 267 M $4.70 B
2025 Q3 251 264 M $4.16 B
2025 Q2 229 275 M $3.06 B
2025 Q1 213 271 M $3.16 B
2024 Q4 222 264 M $3.61 B
2024 Q3 218 266 M $4.44 B
2024 Q2 213 264 M $3.13 B
2024 Q1 209 265 M $3.18 B
2023 Q4 192 256 M $4.31 B
2023 Q3 180 253 M $3.79 B
2023 Q2 188 251 M $4.73 B
2023 Q1 197 250 M $4.47 B
2022 Q4 186 251 M $2.09 B
2022 Q3 195 247 M $1.69 B
2022 Q2 183 250 M $4.91 B
2022 Q1 151 247 M $5.36 B
2021 Q4 152 247 M $5.82 B
2021 Q3 148 245 M $6.40 B
2021 Q2 136 245 M $5.95 B
2021 Q1 134 248 M $6.19 B
2020 Q4 93 303 M $7.55 B